SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +3.2% · posisi baru bersih -5.9% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 19.39K | $353,037 | n/a | −2 |
| Q2 2026 | 109 | +2 | 83.38M | $1.50B | +13 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | n/a |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | n/a |
| Q2 2024 | 13 | n/a | 7.85M | $1.24B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 13.20M | +8.9% | $254.36M | 0.0% | ▲ Add | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (pasif) | 10.82M | +18.1% | $208.45M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasif) | 5.30M | +13.0% | $102.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 2.65M | +324.4% | $51.07M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 2.14M | -1.1% | $41.19M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 2.01M | -55.2% | $38.68M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 1.95M | n/a | $37.54M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | Geode Capital Management ✦ (pasif) | 1.72M | -8.3% | $33.17M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 1.41M | +1015.8% | $26.40M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 10 | JPMorgan Chase ✦ | 1.34M | n/a | $25.80M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 11 | Citadel Advisors ✦ | 512.48K | +69.6% | $9.88M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Bridgewater Associates ✦ | 352.27K | Baru | $6.79M | 0.0% | New | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 284.21K | -73.2% | $5.48M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 177.15K | n/a | $3.41M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Marshall Wace ✦ | 105.11K | Baru | $2.03M | 0.0% | New | 1 | SEC ↗ ×3 |
| 16 | T. Rowe Price ✦ | 90.03K | +17.2% | $1.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Fidelity (FMR) ✦ | 14.37K | +75.4% | $276,993 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Bridgewater Associates | $6.79M | 0.0% |
| Marshall Wace | $2.03M | 0.0% |
Telah keluar
| Wellington Management | $43.27M | adalah 0.0% |
| Norges Bank | $15.62M | adalah 0.0% |
| Fisher Asset Management | $220,761 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 339 pemegang, 102.41M saham, $2.16B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.